These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 11763000

  • 1. The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients.
    Yokono A, Morita S, Someya T, Hirokane G, Okawa M, Shimoda K.
    J Clin Psychopharmacol; 2001 Dec; 21(6):549-55. PubMed ID: 11763000
    [Abstract] [Full Text] [Related]

  • 2. The impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients.
    Shimoda K, Someya T, Yokono A, Morita S, Hirokane G, Takahashi S, Okawa M.
    J Clin Psychopharmacol; 2002 Aug; 22(4):371-8. PubMed ID: 12172336
    [Abstract] [Full Text] [Related]

  • 3. Steady-state plasma concentrations of imipramine and desipramine in relation to S-mephenytoin 4'-hydroxylation status in Japanese depressive patients.
    Koyama E, Tanaka T, Chiba K, Kawakatsu S, Morinobu S, Totsuka S, Ishizaki T.
    J Clin Psychopharmacol; 1996 Aug; 16(4):286-93. PubMed ID: 8835703
    [Abstract] [Full Text] [Related]

  • 4. The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population.
    Fukuda T, Nishida Y, Zhou Q, Yamamoto I, Kondo S, Azuma J.
    Eur J Clin Pharmacol; 2000 May; 56(2):175-80. PubMed ID: 10877013
    [Abstract] [Full Text] [Related]

  • 5. Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer.
    Brown JT, Schneiderhan M, Eum S, Bishop JR.
    Pharmacogenomics; 2017 May; 18(7):601-605. PubMed ID: 28470111
    [Abstract] [Full Text] [Related]

  • 6. Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population.
    Bathum L, Skjelbo E, Mutabingwa TK, Madsen H, Hørder M, Brøsen K.
    Br J Clin Pharmacol; 1999 Sep; 48(3):395-401. PubMed ID: 10510152
    [Abstract] [Full Text] [Related]

  • 7. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG, Caputi AP, D'Arrigo C, Fava G, Spina E.
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [Abstract] [Full Text] [Related]

  • 8. Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers.
    Steimer W, Zöpf K, von Amelunxen S, Pfeiffer H, Bachofer J, Popp J, Messner B, Kissling W, Leucht S.
    Clin Chem; 2004 Sep; 50(9):1623-33. PubMed ID: 15205367
    [Abstract] [Full Text] [Related]

  • 9. Genotypes for the cytochrome P450 enzymes CYP2D6 and CYP2C19 in human longevitY. Role of CYP2D6 and CYP2C19 in longevity.
    Bathum L, Andersen-Ranberg K, Boldsen J, Brøsen K, Jeune B.
    Eur J Clin Pharmacol; 1998 Jul; 54(5):427-30. PubMed ID: 9754988
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma.
    Mochizuki J, Murakami S, Sanjo A, Takagi I, Akizuki S, Ohnishi A.
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1191-7. PubMed ID: 16048566
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine.
    Scordo MG, Spina E, Dahl ML, Gatti G, Perucca E.
    Basic Clin Pharmacol Toxicol; 2005 Nov; 97(5):296-301. PubMed ID: 16236141
    [Abstract] [Full Text] [Related]

  • 15. The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers.
    Tamminga WJ, Wemer J, Oosterhuis B, de Zeeuw RA, de Leij LF, Jonkman JH.
    Eur J Clin Pharmacol; 2001 Dec; 57(10):717-22. PubMed ID: 11829201
    [Abstract] [Full Text] [Related]

  • 16. Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups.
    Luo HR, Aloumanis V, Lin KM, Gurwitz D, Wan YJ.
    Am J Pharmacogenomics; 2004 Dec; 4(6):395-401. PubMed ID: 15651900
    [Abstract] [Full Text] [Related]

  • 17. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.
    Aynacioglu AS, Sachse C, Bozkurt A, Kortunay S, Nacak M, Schröder T, Kayaalp SO, Roots I, Brockmöller J.
    Clin Pharmacol Ther; 1999 Aug; 66(2):185-92. PubMed ID: 10460072
    [Abstract] [Full Text] [Related]

  • 18. Genetic polymorphism of CYP2D6 and CYP2C19 in east- and southern African populations including psychiatric patients.
    Dandara C, Masimirembwa CM, Magimba A, Sayi J, Kaaya S, Sommers DK, Snyman JR, Hasler JA.
    Eur J Clin Pharmacol; 2001 Apr; 57(1):11-7. PubMed ID: 11372584
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.